This case study showcases the collaboration between Discovery Life Sciences (Discovery) and Miltenyi Biotec, two market-leading flow cytometry experts, to develop a customized flow cytometry workflow for a biopharma client seeking to minimize unwanted cell-type contamination during the isolation of matched PBMCs and T cells.